Cargando…

Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices

Background: Stem cells characterized by self-renewal and therapeutic resistance play crucial roles in bladder cancer (BLCA). However, the genes modulating the maintenance and proliferation of BLCA stem cells are still unclear. In this study, we aimed to characterize the expression of stem cell-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Shen, Zhan, Yunhong, Chen, Xiaonan, Wu, Bin, Liu, Bitian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620567/ https://www.ncbi.nlm.nih.gov/pubmed/31334127 http://dx.doi.org/10.3389/fonc.2019.00613

Ejemplares similares

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
por: Pan, Shen, et al.
Publicado: (2019)

Identification of a Gene Signature for Renal Cell Carcinoma–Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis
por: Liu, Bitian, et al.
Publicado: (2021)

Immune status for monitoring and treatment of bladder cancer
por: Pan, Shen, et al.
Publicado: (2022)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
por: Giulietti, Matteo, et al.
Publicado: (2018)

Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?
por: Liu, Bitian, et al.
Publicado: (2018)

Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer
por: Mao, Deli, et al.
Publicado: (2021)

Identification of Immune-Related Therapeutically Relevant Biomarkers in Breast Cancer and Breast Cancer Stem Cells by Transcriptome-Wide Analysis: A Clinical Prospective Study
por: Wang, Linbang, et al.
Publicado: (2021)

Cancer Stem Cell Characteristics by Network Analysis of Transcriptome Data Stemness Indices in Breast Carcinoma
por: Wu, Zeng-hong, et al.
Publicado: (2020)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics
por: Cui, Yunlong, et al.
Publicado: (2021)

NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics
por: Jeon, Seon-Ae, et al.
Publicado: (2020)

Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer
por: Liang, Yichao, et al.
Publicado: (2021)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
por: Zakaria, Norashikin, et al.
Publicado: (2018)

Metabolomics of Non-muscle Invasive Bladder Cancer: Biomarkers for Early Detection of Bladder Cancer
por: Cheng, Xiangming, et al.
Publicado: (2018)

Identification of hub genes and compounds controlling ovarian cancer stem cell characteristics via stemness indices analysis
por: Wang, Zhi, et al.
Publicado: (2021)

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer
por: Li, Shijie, et al.
Publicado: (2023)

Editorial: Identifying novel biomarkers in bladder cancer
por: Ecke, Thorsten H., et al.
Publicado: (2023)

Cervical Cancer Stem-Like Cell Transcriptome Profiles Predict Response to Chemoradiotherapy
por: Zuccherato, Luciana W., et al.
Publicado: (2021)

VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function
por: Yang, Mengying, et al.
Publicado: (2022)

Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
por: Wang, Song, et al.
Publicado: (2022)

CircRNAs: Emerging Bladder Cancer Biomarkers and Targets
por: Liang, Zhaofeng, et al.
Publicado: (2021)

Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction
por: Lyu, Xiaoyue, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Comprehensive analysis of transcriptome data stemness indices identifies key genes for controlling cancer stem cell characteristics in gastric cancer
por: Xia, Xinxin, et al.
Publicado: (2020)

Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis
por: Pei, Jianying, et al.
Publicado: (2020)

Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem
por: Luo, Yongxiang, et al.
Publicado: (2022)

Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Non-muscle invasive bladder cancer biomarkers beyond morphology
por: De Carlo, Camilla, et al.
Publicado: (2022)

Identifying novel biomarkers associated with bladder cancer treatment outcomes
por: Castaneda, Peris R., et al.
Publicado: (2023)

Activation of Glucocorticoid Receptor Inhibits the Stem-Like Properties of Bladder Cancer via Inactivating the β-Catenin Pathway
por: Xu, Congcong, et al.
Publicado: (2020)

Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells
por: Chen, Ru, et al.
Publicado: (2020)

Pan-cancer Landscape of the RUNX Protein Family Reveals their Potential as Carcinogenic Biomarkers and the Mechanisms Underlying their Action
por: Pan, Shen, et al.
Publicado: (2022)

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
por: Bai, Kun‐Hao, et al.
Publicado: (2020)

Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)

Targeting breast cancer stem cells directly to treat refractory breast cancer
por: Pan, Liping, et al.
Publicado: (2023)

Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
por: Chan, Tze-Sian, et al.
Publicado: (2019)

Identification of endothelial-related molecular subtypes for bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dkg41h0v08j2dbtrrr1k30871m